Pierre Loap, MD

Institut Curie

Disclosures:

Presentations

Sep 29

262 - Safety and potential radiosensitizing effect of Olaparib in combination with breast radiotherapy for TNBC patients with residual disease: long-term results from a phase I trial
05:40pm - 05:50pm PT
Sep 29

2971 - Survival Determinants and Toxicity of Second-Course Radiotherapy for Isolated Nodal Recurrencein Breast Cancer
Hall F
03:00pm - 04:00pm PT